Cargando…

Second Malignant Neoplasms Following Radiotherapy

More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhoo...

Descripción completa

Detalles Bibliográficos
Autor principal: Kumar, Sanath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546788/
https://www.ncbi.nlm.nih.gov/pubmed/23249860
http://dx.doi.org/10.3390/ijerph9124744
_version_ 1782256112731422720
author Kumar, Sanath
author_facet Kumar, Sanath
author_sort Kumar, Sanath
collection PubMed
description More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy.
format Online
Article
Text
id pubmed-3546788
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-35467882013-02-09 Second Malignant Neoplasms Following Radiotherapy Kumar, Sanath Int J Environ Res Public Health Review More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy. MDPI 2012-12-18 2012-12 /pmc/articles/PMC3546788/ /pubmed/23249860 http://dx.doi.org/10.3390/ijerph9124744 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kumar, Sanath
Second Malignant Neoplasms Following Radiotherapy
title Second Malignant Neoplasms Following Radiotherapy
title_full Second Malignant Neoplasms Following Radiotherapy
title_fullStr Second Malignant Neoplasms Following Radiotherapy
title_full_unstemmed Second Malignant Neoplasms Following Radiotherapy
title_short Second Malignant Neoplasms Following Radiotherapy
title_sort second malignant neoplasms following radiotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546788/
https://www.ncbi.nlm.nih.gov/pubmed/23249860
http://dx.doi.org/10.3390/ijerph9124744
work_keys_str_mv AT kumarsanath secondmalignantneoplasmsfollowingradiotherapy